Allcutt D, Michowiz S, Weitzman S, Becker L, Blaser S, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT (1993) Primary leptomeningeal melanoma: an unusually aggressive tumor in childhood. Neurosurgery 32 (5):721-729; discussion 729. doi:10.1227/00006123-199305000-00004
Andersen KK, Olsen TS (2018) Risk of Ischemic and Hemorrhagic Strokes in Occult and Manifest Cancers. Stroke 49 (7):1585-1592. doi:10.1161/STROKEAHA.118.021373
Arai N, Kagami H, Mine Y, Ishii T, Inaba M (2018) Primary Solitary Intracranial Malignant Melanoma: A Systematic Review of Literature. World Neurosurg 117:386-393. doi:10.1016/j.wneu.2018.06.138
Arvanitis CD, Ferraro GB, Jain RK (2020) The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 20 (1):26-41. doi:10.1038/s41568-019-0205-x
Assi R, Hamieh L, Mukherji D, Haydar A, Temraz S, El-Dika I, Shamseddine A (2015) Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature. J Gastrointest Oncol 6 (6):E89-E101. doi:10.3978/j.issn.2078-6891.2015.087
Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22 (14):2865-2872. doi:10.1200/JCO.2004.12.149
Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS (1995) Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 76 (9):1665-1670. doi:10.1002/1097-0142(19951101)76:9<1665::aid-cncr2820760925>3.0.co;2-j
Brat DJ, Giannini C, Scheithauer BW, Burger PC (1999) Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 23 (7):745-754
Byun J, Park ES, Hong SH, Cho YH, Kim YH, Kim CJ, Kim JH, Lee S (2018) Clinical outcomes of primary intracranial malignant melanoma and metastatic intracranial malignant melanoma. Clin Neurol Neurosurg 164:32-38. doi:10.1016/j.clineuro.2017.11.012
Corbin ZA, Nagpal S (2016) Leptomeningeal Metastases. JAMA Oncol 2 (6):839. doi:10.1001/jamaoncol.2015.3502
Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, Marquez-Rodas I, Del Vecchio M, Lebbe C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV (2017) Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol 18 (7):863-873. doi:10.1016/S1470-2045(17)30429-1
Dupin E, Le Douarin NM (2003) Development of melanocyte precursors from the vertebrate neural crest. Oncogene 22 (20):3016-3023. doi:10.1038/sj.onc.1206460
Eroglu Z, Ribas A (2016) Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy. Ther Adv Med Oncol 8 (1):48-56. doi:10.1177/1758834015616934
Gibson JB, Burrows D, Weir WP (1957) Primary melanoma of the meninges. The Journal of Pathology and Bacteriology 74 (2):419-438. doi:10.1002/path.1700740220
Goyal S, Silk AW, Tian S, Mehnert J, Danish S, Ranjan S, Kaufman HL (2015) Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review. JAMA Oncol 1 (5):668-676. doi:10.1001/jamaoncol.2015.1206
Greco Crasto S, Soffietti R, Bradac GB, Boldorini R (2001) Primitive cerebral melanoma: case report and review of the literature. Surg Neurol 55 (3):163-168; discussion 168
Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330 (6009):1410-1413. doi:10.1126/science.1194472
Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM (2013) Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 45 (2):133-135. doi:10.1038/ng.2523
Harstad L, Hess KR, Groves MD (2008) Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Neuro Oncol 10 (6):1010-1018. doi:10.1215/15228517-2008-062
Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L (2012) A landscape of driver mutations in melanoma. Cell 150 (2):251-263. doi:10.1016/j.cell.2012.06.024
Hung PC, Chang YC, Hsieh MY, Wu CT (2019) Primary intracranial meningeal melanoma mimicking chronic meningitis: A case report. Pediatr Neonatol 60 (5):589-591. doi:10.1016/j.pedneo.2018.10.003
Keep RF, Zhou N, Xiang J, Andjelkovic AV, Hua Y, Xi G (2014) Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS 11:18. doi:10.1186/2045-8118-11-18
Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, Schutz H (1987) Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 67 (6):852-857. doi:10.3171/jns.1987.67.6.0852
Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44 (9):1006-1014. doi:10.1038/ng.2359
Kusters-Vandevelde HV, Klaasen A, Kusters B, Groenen PJ, van Engen-van Grunsven IA, van Dijk MR, Reifenberger G, Wesseling P, Blokx WA (2010) Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 119 (3):317-323. doi:10.1007/s00401-009-0611-3
Kusters-Vandevelde HV, Kusters B, van Engen-van Grunsven AC, Groenen PJ, Wesseling P, Blokx WA (2015) Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects. Brain Pathol 25 (2):209-226. doi:10.1111/bpa.12241
Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, Ferrucci PF, Hill A, Wagstaff J, Carlino MS, Haanen JB, Maio M, Marquez-Rodas I, McArthur GA, Ascierto PA, Long GV, Callahan MK, Postow MA, Grossmann K, Sznol M, Dreno B, Bastholt L, Yang A, Rollin LM, Horak C, Hodi FS, Wolchok JD (2015) Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 373 (1):23-34. doi:10.1056/NEJMoa1504030
Li CB, Song LR, Li D, Weng JC, Zhang LW, Zhang JT, Wu Z (2019) Primary intracranial malignant melanoma: proposed treatment protocol and overall survival in a single-institution series of 15 cases combined with 100 cases from the literature. J Neurosurg:1-12. doi:10.3171/2018.11.JNS181872
Licata B, Turazzi S (2003) Bleeding cerebral neoplasms with symptomatic hematoma. J Neurosurg Sci 47 (4):201-210; discussion 210
Liubinas SV, Maartens N, Drummond KJ (2010) Primary melanocytic neoplasms of the central nervous system. J Clin Neurosci 17 (10):1227-1232. doi:10.1016/j.jocn.2010.01.017
Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, Wilmott JS, Edwards J, Gonzalez M, Scolyer RA, Menzies AM, McArthur GA (2018) Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol 19 (5):672-681. doi:10.1016/S1470-2045(18)30139-6
Ma Y, Gui Q, Lang S (2015) Intracranial malignant melanoma: A report of 7 cases. Oncol Lett 10 (4):2171-2175. doi:10.3892/ol.2015.3537
Martin M, Masshofer L, Temming P, Rahmann S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L, Hinnebusch AG, Horsthemke B, Lohmann DR, Zeschnigk M (2013) Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 45 (8):933-936. doi:10.1038/ng.2674
Pan Z, Yang G, He H, Yuan T, Wang Y, Li Y, Shi W, Gao P, Dong L, Zhao G (2018) Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication. Sci Rep 8 (1):10445. doi:10.1038/s41598-018-28662-w
Pluim D, Ros W, van Bussel MTJ, Brandsma D, Beijnen JH, Schellens JHM (2019) Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid. J Pharm Biomed Anal 164:128-134. doi:10.1016/j.jpba.2018.10.025
Primoz S (2010) Role of radiotherapy in melanoma management (.pdf, 107 kB). Radiology and Oncology 44 (1)
Puyana C, Denyer S, Burch T, Bhimani AD, McGuire LS, Patel AS, Mehta AI (2019) Primary Malignant Melanoma of the Brain: A Population-Based Study. World Neurosurg 130:e1091-e1097. doi:10.1016/j.wneu.2019.07.095
Rodriguez y Baena R, Gaetani P, Danova M, Bosi F, Zappoli F (1992) Primary solitary intracranial melanoma: case report and review of the literature. Surg Neurol 38 (1):26-37
Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K (2018) Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. N Engl J Med 379 (8):722-730. doi:10.1056/NEJMoa1805453
van Bussel MTJ, Beijnen JH, Brandsma D (2019) Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review. BMC Cancer 19 (1):519. doi:10.1186/s12885-019-5741-y
van de Nes J, Gessi M, Sucker A, Moller I, Stiller M, Horn S, Scholz SL, Pischler C, Stadtler N, Schilling B, Zimmer L, Hillen U, Scolyer RA, Buckland ME, Lauriola L, Pietsch T, Waha A, Schadendorf D, Murali R, Griewank KG (2016) Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system. J Neurooncol 127 (3):435-444. doi:10.1007/s11060-015-2052-2
Wronski M, Arbit E (2000) Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 93 (1):9-18. doi:10.3171/jns.2000.93.1.0009
Zheng YC, Jung SM, Chang JWC, Huang YC (2013) Primary intramedullary melanoma: A case report and review of literature. Chirurgia (Turin) 26:411-414